Looking Into Syros Pharmaceuticals's Recent Short Interest By: Benzinga via Benzinga October 05, 2022 at 11:36 AM EDT Syros Pharmaceuticals's (NASDAQ:SYRS) short percent of float has fallen 48.18% since its last report. The company recently reported ... Read More >> Related Stocks: Syros Pharmaceuticals